Morrison & Foerster’s ‘dedicated' practice handles a broad range of transactional issues within the technology sector, in addition to e-commerce, biotech, and online gaming. Thomas Chou is particularly active on transactions within the TMT and life sciences spaces, while Marcia Ellis maintains a private equity focused practice and regularly assists SPACs. Maureen Ho has broad experience in leveraged buy-outs, joint ventures, and bolt-on acquisitions. Vivian Yiu frequently acts for both state owned and private Chinese enterprises in matters involving mandatory cash offers.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘They work really hard when dealing with different timezones. Have a good understanding of that are the key issues and able to help negotiate with different parties. Very professional throughout the process.’

  • ‘Professional. Dedicated. Always available and very tactful in dealing with complex issues. Thomas Chou is a great leader.’

Key clients

  • Alibaba Group
  • Arm Limited
  • GLP
  • Jamieson Wellness
  • Softbank
  • Softbank Vision Fund
  • Silver Crest

Work highlights

  • Advised SoftBank Group Corp. and SoftBank Vision Fund on their acquisition of a substantial interest in Arm China, as a necessary step enabling the planned listing of Arm Limited.
  • Advised Alibaba Group Holding Limited in the renegotiation and amendment of various agreements between AGH and Ant Group Co., Ltd. related to AGH’s acquisition of a 33% stake in Ant, China’s leading financial services and technology company.
  • Advised Amperex Technology Limited in its RMB14 bn joint ventures for mid-size battery cells and packs and US$1.5 bn technology cross-license arrangement with Contemporary Amperex Technology Co., Limited.

Practice head

The lawyer(s) leading their teams.

Thomas Chou, Marcia Ellis, Maureen Ho, Paul McKenzie, Chuan Sun, Vivian Yiu